ESQ · Esquire Financial Holdings $123.25 -0.41 (-0.34%) 2026-SEP-18 12:20 EST

In short: BUY, and one of the few rated Buy while expensive against its own history: fwd PE 16.0 against an 11.9 five-year average — 34.5% overvalued — carried by 13.5% EPS growth, a 13.48% expected return and an RDCF gap of +7.5pp. The universe's strongest five-year CAGR at 39.0%; YTD +25.9%.

In short: BUY, and the universe's best five-year compounder at 39.5% a year, up 18.8% YTD. FV $194.5 vs $120.3 = 38.1% under; fwd PE 16.0 against an 11.9 average — 34.5% over on the multiple test; RDCF 3.0% vs 13.5% expected. Also fourteenth on the reverse-DCF screen.

In short: BUY, and the list's best five-year compounder at 35.3% a year. FV $174.7 vs $108.1 = 38.1% under; fwd PE 16.0 against an 11.9 average — i.e. 34.5% overvalued on the multiple test, the only Buy where the current multiple is well above its own history; the reverse DCF disagrees strongly the other way (4.4% required vs 13.5% expected). Also fifteenth on the RDCF screen.

In short: BUY. EPS growth 13.50%, dividend 0.80%, FWD PE 16 against a fair exit 15, expected return 13.68%, fair value 175.7 against 106.9 = 39.20% undervalued.

In short: BUY while trading 34.5% above its own five-year multiple (16.0x against 11.9x) — carried entirely by growth: 13.5% expected EPS growth, a +9.1pp reverse-DCF margin and the best five-year record on the sheet at a 36.8% CAGR. One of only three Buys with a positive year to date (+5.9%).

In short: UPGRADED Hold → Buy — "a specialty bank focused on the legal industry." Trades 34.5% above its own five-year multiple (16.0x against 11.9x), so the case is entirely growth and DCF: 13.5% EPS growth, a 13.6% expected return, a $172.6 fair value against $106.79 (38.1% under), and a +8.2pp reverse-DCF margin. Third-best five-year CAGR in the whole watchlist at 41.9%.